XML 50 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Deficit) (Details Narrative) - USD ($)
3 Months Ended
Dec. 19, 2017
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Sep. 13, 2017
Class of Stock [Line Items]            
Preferred stock, shares authorized   20,000,000   20,000,000   20,000,000
Preferred stock par value   $ 0.001   $ 0.001   $ 0.001
Common stock par value   $ 0.001   $ 0.001   $ 0.001
Common stock, shares authorized   300,000,000   300,000,000   300,000,000
Common stock, shares issued   17,483,283   17,483,283    
Common stock, shares outstanding   17,483,283   17,483,283    
Common stock to be issued, shares outstanding   651,281 4,505,431 651,281    
Deemed dividend   $ (160,479)      
Stock Options [Member]            
Class of Stock [Line Items]            
Stock compensation expense   $ 5,408 $ 0      
Number of option to purchase   375,000        
Stock compensation expense remains unrecognized   $ 48,668        
Weighted average period   2 years 2 months 30 days        
Two Initial Shareholders [Member]            
Class of Stock [Line Items]            
Common stock to be issued, shares outstanding   30,000        
IAR Agreements [Member]            
Class of Stock [Line Items]            
Common stock to be issued, shares outstanding   621,281        
Stock Issuance and Release Agreements [Member]            
Class of Stock [Line Items]            
Number of common stock to be issued     891,551      
Shares issued price per share     $ 0.18   $ 1.85  
Deemed dividend     $ 160,479      
Sale of stock price per shares     $ 0.18      
License Agreement [Member] | Massachusetts General Hospital [Member]            
Class of Stock [Line Items]            
Number of common stock to be issued     3,612,880      
Series A Preferred Stock [Member]            
Class of Stock [Line Items]            
Preferred stock, shares authorized 3,000,000 3,000,000   3,000,000    
Preferred stock par value $ 0.001 $ 0.001   $ 0.001    
Preferred stock voting rights Each holder of shares of Series A Preferred Stock shall be entitled to the number of votes equal to the number of votes held by the number of shares of common stock into which such share of Series A Preferred Stock could be converted, and except as otherwise required by applicable law, shall have the voting rights and power equal to the voting rights and powers of the common stock.          
Preferred stock converted per shares 167.00%          
Preferred stock conversion, description Each share of Series A Preferred Stock is convertible into shares of common stock at a conversion Rate of 2:1 (the "Series A Conversion Rate").          
Preferred stock, shares issued   3,000,000   3,000,000    
Preferred stock, shares outstanding   3,000,000   3,000,000    
Series B Preferred Stock [Member]            
Class of Stock [Line Items]            
Preferred stock, shares authorized 4,440,000 4,440,000   4,440,000    
Preferred stock par value $ 0.001 $ 0.001   $ 0.001    
Preferred stock voting rights Each holder of shares of Series B Preferred Stock shall be entitled to the number of votes equal to the number of votes held by the number of shares of common stock into which such share of Series B Preferred Stock could be converted, and except as otherwise required by applicable law, shall have the voting rights and power equal to the voting rights and powers of the common stock.          
Preferred stock converted per shares 83.00%          
Preferred stock conversion, description Each share of Series B Preferred Stock is convertible into shares of common stock at a conversion rate of 2:1 (the "Series B Conversion Rate").          
Preferred stock, shares issued   4,440,000   4,440,000    
Preferred stock, shares outstanding   4,440,000   4,440,000